NATCO Pharma Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 10,314 million compared to INR 4,321 million a year ago. Revenue was INR 10,608 million compared to INR 4,526 million a year ago. Net income was INR 3,690 million compared to INR 568 million a year ago. Basic earnings per share from continuing operations was INR 20.6 compared to INR 3.11 a year ago. Diluted earnings per share from continuing operations was INR 20.6 compared to INR 3.11 a year ago.
For the six months, sales was INR 21,719 million compared to INR 13,167 million a year ago. Revenue was INR 22,210 million compared to INR 13,715 million a year ago. Net income was INR 7,893 million compared to INR 3,772 million a year ago. Basic earnings per share from continuing operations was INR 43.88 compared to INR 20.66 a year ago. Diluted earnings per share from continuing operations was INR 43.88 compared to INR 20.66 a year ago.